ABLYNX NV Financials

ABLYNX NV Stock Summary

ABLYNX NV competes with Catalyst Pharmaceuticals, Mind Medicine, Akanda Corp, Acumen Pharmaceuticals, and Aquestive Therapeutics. Ablynx NV, a late-stage clinical biopharmaceutical company, develops treatments for a range of therapeutic indications. As of May 4, 2018, Ablynx NV operates as a subsidiary of Sanofi. Ablynx NV operates under Biotechnology classification in USA and traded on NASDAQ. It employs 388 people.

ABLYNX NV Key Financial Ratios

ABLYNX Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ABLYNX NV's current stock value. Our valuation model uses many indicators to compare ABLYNX NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABLYNX NV competition to find correlations between indicators driving ABLYNX NV's intrinsic value. More Info.ABLYNX NV is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ABLYNX NV's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

If you are still planning to invest in ABLYNX NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABLYNX NV's history and understand the potential risks before investing.